2017/06/12 Reven News Press

The US Patent and Trademark Office (USPTO) allowed Reven RJX Family One Child Patent, application # 14,550,677. This is our "method of treating” patent.

2017/06/12 Reven News Press2020-01-22T11:14:12-05:00

06/05/2017 Reven News Press

Reven initiates Phase I Clinical Trial in Australia to run in conjunction with planned Phase I/IIa in the USA

06/05/2017 Reven News Press2017-12-02T16:20:20-05:00

2017/06/05 Reven News Press

Reven initiates Phase I Clinical Trial in Australia to run in conjunction with planned Phase I/IIa in the USA.

2017/06/05 Reven News Press2020-01-22T11:12:02-05:00

2017/02/01 Reven News Press

After months of vetting, Reven, selected INC Research clinical research organization (CRO) partner. They will be assisting with administration, project management, and execution of the various processes involved in patient care delivery throughout the trial.

2017/02/01 Reven News Press2020-01-22T11:07:32-05:00